Keith M Wilcoxen

This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignees: Neurocrine Biosciences, Inc., Other. Active years: 2002-2006.

USPTO Granted Patents = 8 (Patent Applications = 4)

% Patents Active = 87.5

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 35(Granted Patents)

Location History:

Groton Long Point, CA (US) (2003)
San Diego, CA (US) (2002 - 2006)

Company Filing History:

5 out of 123

Neurocrine Biosciences, Inc.

patents

3 out of 834,411

Other

patents

Years Active: 2002-2006

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7074797 - Pyrazolopyrimidines as CRF receptor antagonists (2006-07-11),

2. 7034154 - Synthesis of substituted pyrazolopyrimidines (2006-04-25),

3. 6664261 - Pyrazolopyrimidines as CRF receptor antagonists (2003-12-16),

4. 6613777 - CRF antagonistic pyrazolo[4,3-b]pyridines (2003-09-02),

5. 6610678 - CRF antagonistic quino-and quinazolines (2003-08-26),

6. 6482836 - CRF antagonistic quino- and quinazolines (2002-11-19),

7. 6472528 - Synthesis of substituted pyrazolopyrimidines (2002-10-29),

8. 6346534 - Gonadotropin-releasing hormone receptor antagonists and methods relating thereto (2002-02-12),

Title: The Innovative Mind of Keith M Wilcoxen

Introduction

Keith M Wilcoxen, an accomplished inventor based in San Diego, CA, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 8 patents, Wilcoxen has focused primarily on the development of compounds that possess valuable therapeutic properties.

Latest Patents

Among his latest inventions are groundbreaking patents concerning pyrazolopyrimidines, which act as CRF receptor antagonists. These inventions detail compounds characterized by specific formulas that include various stereoisomers and pharmaceutically acceptable acid addition salt forms. The utility of these compounds spans the treatment of several disorders related to hypersecretion of CRF, including depression, anxiety, and substance abuse. Another notable patent of Wilcoxen involves methods for synthesizing substituted pyrazolopyrimidines that do not require the isolation of intermediate pyrazoles. These improved techniques not only enhance efficiency but also cater to large-scale manufacturing needs, showcasing his innovative approach to pharmaceutical chemistry.

Career Highlights

Throughout his career, Keith Wilcoxen has made impactful strides while working at prominent companies such as Neurocrine Biosciences, Inc. His work has led to significant advancements in understanding and treating various psychological disorders through innovative medicinal compounds.

Collaborations

Wilcoxen has collaborated with distinguished professionals in the field, including Chen Chen and James R McCarthy. These collaborations exemplify the teamwork and collective expertise that have enriched his research and inventions.

Conclusion

Keith M Wilcoxen stands out as a prominent innovator whose groundbreaking patents and collaborations have had a substantial impact on the pharmaceutical industry. His dedication to enhancing therapeutic options showcases the power of innovation in addressing complex health challenges.